Gurudev K C, Pathak V, Prabhakar K S, Bhaskar S, Prakash K C, Mani M K
Department of Nephrology, Apollo Hospitals, Madras.
J Assoc Physicians India. 1991 Dec;39(12):921-4.
We did a double blind, crossover, prospective study comparing bicarbonate and acetate containing solutions in haemodialysis. Thirty stable patients with end stage renal disease on maintenance haemodialysis while awaiting a renal transplant were each studied on three dialysis with acetate and three with bicarbonate. Nine patients developed symptoms like headache, nausea, vomiting, giddiness, and malaise and developed hypotension during acetate dialysis and three patients during bicarbonate dialysis. There were symptoms during 16.66% of acetate dialysis sessions and 5.55% of bicarbonate dialysis sessions. (P less than 0.05). There was a statistically significant decrease in PaO2 and PaCO2 on acetate dialysis at 30 minutes after initiation of dialysis. There was no significant difference in weight loss on dialysis, or in blood pressure and correction of acidosis. We conclude that bicarbonate dialysis is better tolerated, but acetate intolerance is not a major problem since we use small surface area dialysers (0.8 M2).
我们进行了一项双盲、交叉、前瞻性研究,比较血液透析中含碳酸氢盐和醋酸盐的溶液。30例等待肾移植的维持性血液透析终末期肾病稳定患者,分别接受了3次醋酸盐透析和3次碳酸氢盐透析。9例患者在醋酸盐透析期间出现头痛、恶心、呕吐、头晕和不适等症状,并出现低血压,3例患者在碳酸氢盐透析期间出现这些症状。醋酸盐透析期间16.66%的透析疗程出现症状,碳酸氢盐透析期间为5.55%。(P小于0.05)。透析开始30分钟后,醋酸盐透析时PaO2和PaCO2有统计学意义的下降。透析时体重减轻、血压及酸中毒纠正方面无显著差异。我们得出结论,碳酸氢盐透析耐受性更好,但由于我们使用小表面积透析器(0.8 M2),醋酸盐不耐受不是主要问题。